These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20936623)

  • 21. Self-assembled drug delivery systems. Part 5: self-assemblies of a bolaamphiphilic prodrug containing dual zidovudine.
    Jin Y; Qi N; Tong L; Chen D
    Int J Pharm; 2010 Feb; 386(1-2):268-74. PubMed ID: 19941945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of new covalently bound kappa-carrageenan-AZT conjugates with improved anti-HIV activities.
    Vlieghe P; Clerc T; Pannecouque C; Witvrouw M; De Clercq E; Salles JP; Kraus JL
    J Med Chem; 2002 Mar; 45(6):1275-83. PubMed ID: 11881996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
    Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
    ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-HIV therapy with AZT prodrugs: AZT phosphonate derivatives, current state and prospects.
    Khandazhinskaya A; Matyugina E; Shirokova E
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):701-14. PubMed ID: 20380483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate.
    Yang L; Chen L; Zeng R; Li C; Qiao R; Hu L; Li Z
    Bioorg Med Chem; 2010 Jan; 18(1):117-23. PubMed ID: 19959368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5'-aminocarbonyl phosphonates as new zidovudine depot forms: antiviral properties, intracellular transformations, and pharmacokinetic parameters.
    Khandazhinskaya AL; Yanvarev DV; Jasko MV; Shipitsin AV; Khalizev VA; Shram SI; Skoblov YS; Shirokova EA; Kukhanova MK
    Drug Metab Dispos; 2009 Mar; 37(3):494-501. PubMed ID: 19106116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles.
    Dalpiaz A; Ferraro L; Perrone D; Leo E; Iannuccelli V; Pavan B; Paganetto G; Beggiato S; Scalia S
    Mol Pharm; 2014 May; 11(5):1550-61. PubMed ID: 24717116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of bis(t-butyl-SATE)-AZTMP, a bispivaloylthioethyl prodrug for intracellular delivery of zidovudine monophosphate, in mice.
    Tan X; Boudinot FD; Chu CK; Egron D; Perigaud C; Gosselin G; Imbach JL
    Antivir Chem Chemother; 2000 May; 11(3):203-11. PubMed ID: 10901291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
    Parang K; Wiebe LI; Knaus EE
    Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative determination of zidovudine diaryl phosphate triester pro-drugs in rat plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Zhu M; Xie B; Tang G; Hu A; Fang M; Wu Z; Zhao Y
    J Pharm Biomed Anal; 2008 Dec; 48(5):1417-24. PubMed ID: 19118970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, anti-HIV activity, and stability studies of 5'-phosphorofluoridate derivatives of AZT.
    Egron D; Arzumanov AA; Dyatkina NB; Aubertin AM; Imbach JL; Gosselin G; Krayevsky A; Périgaud C
    Bioorg Chem; 2001 Dec; 29(6):333-44. PubMed ID: 11846432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(ethylene glycol) enclatherated pectin-mucin submicron matrices for intravaginal anti-HIV-1 drug delivery.
    Mashingaidze F; Choonara YE; Kumar P; du Toit LC; Maharaj V; Buchmann E; Pillay V
    Int J Pharm; 2016 Apr; 503(1-2):16-28. PubMed ID: 26943973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and tissue distribution of (+/-)-3'-azido-2',3'-dideoxy-5'-O-(2-bromomyristoyl)thymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine (AZT) in mice.
    Parang K; Wiebe LI; Knaus EE
    J Pharm Pharmacol; 1998 Sep; 50(9):989-96. PubMed ID: 9811159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-assembled drug delivery systems. Part 4. In vitro/in vivo studies of the self-assemblies of cholesteryl-phosphonyl zidovudine.
    Jin Y; Xing L; Tian Y; Li M; Gao C; Du L; Dong J; Chen H
    Int J Pharm; 2009 Oct; 381(1):40-8. PubMed ID: 19646518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New dinucleoside phosphonate derivatives as prodrugs of 3'-azido-3'-deoxythymidine and β-L-2',3'-dideoxy-3'-thiacytidine: synthesis and anti-HIV properties.
    Solyev PN; Jasko MV; Karpenko IL; Sharkin YA; Shipitsyn AV; Kukhanova MK
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(2):64-79. PubMed ID: 24660881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Existence of a flip-flop kinetic model for zidovudine (AZT) after oral administration.
    Melvin GC; Ellison SR; Monk CM; Bates TR
    Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):193-204. PubMed ID: 2277865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo study of poly(ethylene glycol) conjugated ketoprofen to extend the duration of action.
    Choi HK; Chun MK; Lee SH; Jang MH; Kim HD; Jung CS; Oh SY
    Int J Pharm; 2007 Aug; 341(1-2):50-7. PubMed ID: 17517483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, in vitro biological stability, and anti-HIV activity of 5-halo-6-alkoxy(or azido)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs to 3'-azido-3'-deoxythymidine (AZT).
    Kumar R; Wang L; Wiebe LI; Knaus EE
    J Med Chem; 1994 Dec; 37(25):4297-306. PubMed ID: 7996541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and in vitro chemical and enzymatic stability of glycosyl 3'-azido-3'-deoxythymidine derivatives as potential anti-HIV agents.
    Bonina F; Puglia C; Rimoli MG; Avallone L; Abignente E; Boatto G; Nieddu M; Meli R; Amorena M; de Caprariis P
    Eur J Pharm Sci; 2002 Aug; 16(3):167-74. PubMed ID: 12128171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation.
    Vlieghe P; Bihel F; Clerc T; Pannecouque C; Witvrouw M; De Clercq E; Salles JP; Chermann JC; Kraus JL
    J Med Chem; 2001 Mar; 44(5):777-86. PubMed ID: 11262088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.